Monash IVF Group Limited (MVF.AX)

AUD 1.22

(-1.21%)

Operating Income Summary of Monash IVF Group Limited

Monash IVF Group Limited's latest annual operating income in 2024 was -5.34 Million AUD , down -115.25% from previous year.
Monash IVF Group Limited's latest quarterly operating income in 2024 FY was 41.7 Million AUD , up 19.04% from previous quarter.
Monash IVF Group Limited reported an annual operating income of 35.03 Million AUD in 2023, up 13.37% from previous year.
Monash IVF Group Limited reported an annual operating income of 30.9 Million AUD in 2022, down -11.99% from previous year.
Monash IVF Group Limited reported a quarterly operating income of 41.7 Million AUD for 2024 FY, up 19.04% from previous quarter.
Monash IVF Group Limited reported a quarterly operating income of 20.27 Million AUD for 2024 Q2, up 11.19% from previous quarter.

Annual Operating Income Chart of Monash IVF Group Limited (2024 - 2013)

Historical Annual Operating Income of Monash IVF Group Limited (2024 - 2013)

Year	Operating Income	Operating Income Growth
2024	-5.34 Million AUD	-115.25%
2023	35.03 Million AUD	13.37%
2022	30.9 Million AUD	-11.99%
2021	35.11 Million AUD	107.39%
2020	16.93 Million AUD	-48.28%
2019	32.74 Million AUD	-1.25%
2018	33.15 Million AUD	-25.68%
2017	44.61 Million AUD	-1.67%
2016	45.37 Million AUD	19.73%
2015	37.89 Million AUD	5.42%
2014	35.94 Million AUD	17.14%
2013	30.68 Million AUD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q4	-25.61 Million AUD	-226.36%
2024 FY	41.7 Million AUD	19.04%
2024 Q2	20.27 Million AUD	11.19%
2023 Q4	18.23 Million AUD	8.52%
2023 Q2	16.8 Million AUD	45.87%
2023 FY	35.03 Million AUD	13.37%
2022 Q2	19.38 Million AUD	17.91%
2022 Q4	11.51 Million AUD	-40.58%
2022 FY	30.9 Million AUD	-11.99%
2021 FY	35.11 Million AUD	107.39%
2021 Q2	18.41 Million AUD	111.25%
2021 Q4	16.44 Million AUD	-10.71%
2020 Q4	8.71 Million AUD	-33.54%
2020 FY	16.93 Million AUD	-48.28%
2020 Q2	13.11 Million AUD	-17.71%
2019 Q2	16.8 Million AUD	13.76%
2019 FY	32.74 Million AUD	-1.25%
2019 Q4	15.93 Million AUD	-5.14%
2018 Q4	14.77 Million AUD	-19.67%
2018 FY	33.15 Million AUD	-25.68%
2018 Q2	18.38 Million AUD	-14.0%
2017 Q2	23.23 Million AUD	1.32%
2017 FY	44.61 Million AUD	-1.67%
2017 Q4	21.38 Million AUD	-7.97%
2016 FY	45.37 Million AUD	19.73%
2016 Q4	22.92 Million AUD	2.17%
2016 Q2	22.44 Million AUD	11.1%
2015 Q4	20.19 Million AUD	14.14%
2015 FY	37.89 Million AUD	5.42%
2015 Q2	17.69 Million AUD	-3.82%
2014 Q2	17.55 Million AUD	27.28%
2014 FY	35.94 Million AUD	17.14%
2014 Q4	18.39 Million AUD	4.83%
2013 Q4	13.78 Million AUD	-18.4%
2013 FY	30.68 Million AUD	0.0%
2013 Q2	16.89 Million AUD	0.0%

Peer Operating Income Comparison of Monash IVF Group Limited

Name	Operating Income	Operating Income Difference
Australian Clinical Labs Limited	56.9 Million AUD	109.391%
BCAL Diagnostics Limited	-5.44 Million AUD	1.894%
Genetic Signatures Limited	-22.33 Million AUD	76.071%
Genetic Technologies Limited	-6.53 Million AUD	18.252%
Healius Limited	39.7 Million AUD	113.461%
Imagion Biosystems Limited	-15.81 Million AUD	66.208%
Integral Diagnostics Limited	5.36 Million AUD	199.571%
INOVIQ Ltd	-9.51 Million AUD	43.81%
Microba Life Sciences Limited	-26.84 Million AUD	80.092%
Rhythm Biosciences Limited	-6.7 Million AUD	20.325%
Sonic Healthcare Limited	816.45 Million AUD	100.655%